Insights

Gathering insights about Arsanis…

Similar companies to Arsanis

Arsanis Tech Stack

Arsanis uses 8 technology products and services including Google Analytics, Salesforce, Font Awesome, and more. Explore Arsanis's tech stack below.

Google Analytics
Analytics
Salesforce
Customer Relationship Management
Font Awesome
Font Scripts
web-vitals
Javascript Libraries
RSS
Miscellaneous
Priority Hints
Performance
HSTS
Security
Nginx
Web Servers

Media & News

X4 Pharmaceuticals launches X4Connect.
Alongside the approval, X4 launched X4Connect, a support program for U.S. patients, and announced XOLREMDI's commercial availability through PANTHERx(R) Rare, with a set annual cost ranging from $372,300 to $496,400.
Apr 29, 2024 | www.tipranks.com
X4 Pharmaceuticals launches X4Connect to support U.S. patients with resources and assistance programs.
Alongside the drug's release, X4 Pharmaceuticals is also launching X4Connect to support U.S. patients with resources and assistance programs.
Apr 29, 2024 | www.tipranks.com
X4 Pharmaceuticals launches XOLREMDI.
X4 Pharmaceuticals launches XOLREMDI with FDA approval.
Apr 29, 2024 | www.tipranks.com
X4 Pharmaceuticals launches updated corporate presentation on website.
X4 Pharmaceuticals, Inc. has released an updated corporate presentation on their website, accessible through the "Investors" section at www.x4pharma.com.
Apr 01, 2024 | www.tipranks.com
X4 Pharmaceuticals launches What If It.
In anticipation of a potential second quarter 2024 U.S. launch of mavorixafor in WHIM syndrome, X4 has continued to build out its go-to market organization, with key hires across commercial and medical functions, increased interactions with key stakeholders and rare disease patient advocacy organizations, and has launched a disease-awareness campaign called What If It's WHIM?
Nov 08, 2023 | investors.x4pharma.com
X4 Pharmaceuticals hired R. Keith Woods as Board of Directors on Oct 18th '23.
BOSTON, Oct. 18, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced the appointment of R. Keith Woods as an independent director to the company's Board of Directors.
Oct 18, 2023 | www.marketscreener.com
X4 Pharmaceuticals is developing treatments for diseases of the immune system.
At X4 Pharmaceuticals (X4) National Neutropenia Network Inc is currently working to develop treatments for diseases of the immune system, with a focus on rare diseases and those with limited treatment options.
Oct 10, 2023 | forms.office.com

Arsanis's Email Address Formats

Arsanis uses at least 2 format(s):

Arsanis Email Formats	Example	Percentage
First.Last@arsanis.com	John.Doe@arsanis.com	93%
FLast@arsanis.com	JDoe@arsanis.com	7%
First.Last@x4pharma.com	John.Doe@x4pharma.com	100%

Frequently Asked Questions

Where is Arsanis's headquarters located?

Arsanis's main headquarters is located at Winter Street Waltham, MA 02451 US. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Arsanis's phone number?

You can contact Arsanis's main corporate office by phone at

+1-603-727-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Arsanis's stock symbol?

Arsanis is a publicly traded company; the company's stock symbol is XFOR.

What is Arsanis's official website and social media links?

Arsanis's official website is x4pharma.com and has social profiles on LinkedIn.

How much revenue does Arsanis generate?

As of August 2024, Arsanis's annual revenue reached $3.8M.

What is Arsanis's SIC code NAICS code?

Arsanis's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arsanis have currently?

As of August 2024, Arsanis has approximately 11 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Owner: E. N.Owner: L. A.Director Of Finance & Operations: J. S.. Explore Arsanis's employee directory with LeadIQ.

What industry does Arsanis belong to?

Arsanis operates in the Biotechnology Research industry.

What technology does Arsanis use?

Arsanis's tech stack includes Google AnalyticsSalesforceFont Awesomeweb-vitalsRSSPriority HintsHSTSNginx.

What is Arsanis's email format?

Arsanis's email format typically follows the pattern of . Find more Arsanis email formats with LeadIQ.

How much funding has Arsanis raised to date?

As of August 2024, Arsanis has raised $20M in funding. The last funding round occurred on Dec 04, 2017 for $20M.

When was Arsanis founded?

Arsanis was founded in 2010.

Arsanis

Biotechnology ResearchMassachusetts, United States11-50 Employees

Effective March 13, 2019, Arsanis completed a merger with X4 Pharmaceuticals, Inc. For continued news and updates, we encourage you to follow X4 at www.x4pharma.com to stay in touch and learn more.

Company Overview

Headquarters: Winter Street Waltham, MA 02451 US
Phone number: ✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-603-727-****
Website: x4pharma.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: XFOR
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2010
Employees: 11-50

Media & News

Funding & Financials

$20M
Arsanis has raised a total of $20M of funding over 9 rounds. Their latest funding round was raised on Dec 04, 2017 in the amount of $20M.
$10M
Arsanis's revenue is in the range of $10M

Funding & Financials

$20M
Arsanis has raised a total of $20M of funding over 9 rounds. Their latest funding round was raised on Dec 04, 2017 in the amount of $20M.
$10M
Arsanis's revenue is in the range of $10M

Company Leadership

E. N.
Owner
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. A.
Owner
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. S.
Director Of Finance & Operations
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. M.
Clinical Trial Manager
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. C.
Senior Executive Assistant/Office Manager
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

C. P.
Scientist
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. C.
Executive Assistant
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arsanis and Millions of Other Companies
Sign up for full access to Arsanis information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Arsanis

Quell Therapeutics

Generation Bio

Semma Therapeutics

LogicBio Therapeutics

BlueRock Therapeutics

Guardant Health

AVROBIO

Intergamma

Arsanis Tech Stack

Media & News

X4 Pharmaceuticals launches X4Connect.

X4 Pharmaceuticals launches X4Connect to support U.S. patients with resources and assistance programs.

X4 Pharmaceuticals launches XOLREMDI.

X4 Pharmaceuticals launches updated corporate presentation on website.

X4 Pharmaceuticals launches What If It.

X4 Pharmaceuticals hired R. Keith Woods as Board of Directors on Oct 18th '23.

X4 Pharmaceuticals is developing treatments for diseases of the immune system.

Arsanis's Email Address Formats

Frequently Asked Questions

Where is Arsanis's headquarters located?

What is Arsanis's phone number?

What is Arsanis's stock symbol?

What is Arsanis's official website and social media links?

How much revenue does Arsanis generate?

What is Arsanis's SIC code NAICS code?

How many employees does Arsanis have currently?

What industry does Arsanis belong to?

What technology does Arsanis use?

What is Arsanis's email format?

How much funding has Arsanis raised to date?

When was Arsanis founded?

Arsanis

Company Overview

Media & News

X4 Pharmaceuticals launches X4Connect.

X4 Pharmaceuticals launches X4Connect to support U.S. patients with resources and assistance programs.

X4 Pharmaceuticals launches XOLREMDI.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?